Identification of Novel Anthracycline Resistance Genes and Their Inhibitors
Differentially expressed genes have been previously identified by us in multidrug-resistant tumor cells mainly resistant to doxorubicin. In the present study, we exemplarily focused on some of these genes to investigate their causative relationship with drug resistance. <i>HMOX1</i>, <...
Saved in:
Main Authors: | Onat Kadioglu (Author), Mohamed Elbadawi (Author), Edmond Fleischer (Author), Thomas Efferth (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
by: Onat Kadioglu, et al.
Published: (2018) -
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
by: Lucie Čermáková, et al.
Published: (2022) -
The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014) -
Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018) -
Anthracycline extravasation injuries: management with dexrazoxane
by: Karin Jordan, et al.
Published: (2009)